Concepedia

Kayo Umekawa

KU

3

Publications

91

Citations

3

H-Index

2000

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Osaka University of Pharmaceutical Sciences

Kayo Umekawa is an author at Sumitomo Dainippon Pharma (Japan) specializing in drug development, medicine, and drug discovery.

Top concepts

Publications per year

2000–2002

3

Publications

3

Pharmacological Characterization of a Novel Sulfonylureid-Pyrazole Derivative, SM-19712, a Potent Nonpeptidic Inhibitor of Endothelin Converting Enzyme

Kayo Umekawa, Hirohiko Hasegawa, Y Tsutsumi et al. · The Japanese Journal of Pharmacology · 2000 · 42 citations · Full text

, , +16

Protective Effect of SM-19712, a Novel and Potent Endothelin Converting Enzyme Inhibitor, on Ischemic Acute Renal Failure in Rats

Yasuo Matsumura, Toshihiko Kuro, Yutaka Kobayashi et al. · The Japanese Journal of Pharmacology · 2000 · 28 citations · Full text

Design, synthesis and biological activity of novel non-peptidyl endothelin converting enzyme inhibitors, 1-phenyl-tetrazole-formazan analogues

Kazuto Yamazaki, Hirohiko Hasegawa, Kayo Umekawa et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 21 citations · Full text

, , +11

Rows per page

1–3 of 3